CIK 0001501989
- Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273521219
- Phone
- +1 650-515-3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- 4 Exercise or conversion Chief Financial Officer acquired 4,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 93,124 shares (option exercise)
- 4 Other acquisition Director acquired 348,754 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 48,427 shares at an average $10.07 ($487,498)
- 4 Open-market sale Director sold 48,427 shares at an average $10.07 ($487,498)
- 4 Open-market sale Director sold 111,498 shares at an average $10.01 ($1,116,290)
- 4 Open-market sale Director sold 111,498 shares at an average $10.01 ($1,116,290)
- 4 Open-market sale Director sold 59,621 shares at an average $10.80 ($644,048)
- 4 Open-market sale Director sold 59,621 shares at an average $10.80 ($644,048)
- 4 Open-market sale Director sold 22,463 shares at $10.75 ($241,477)
- 4 Open-market sale Director sold 22,463 shares at $10.75 ($241,477)
Page 18 of 20 · 400 filings